- Home
- News
- Blog
- state news
- Andaman And Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra And Nagar Haveli
- Daman And Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
Controversy on Malla Reddy Medical College MBBS Admissions, as college bags MCI approval on last date
The medical college is reported to have bagged the MCI Approval for 150 seats on 31st August, which is incidentally the last date of MBBS admissions for this year as per the law.
Hyderabad: A number of controversial allegations have surfaced against the Malla Reddy Institute of Medical Sciences (MRIMS) claiming that the college administration is selling MBBS convenor seats (government quota) under the cover of getting late Medical Council of India's (MCI) recognition.
As per recent media reports, after getting declined for the recognition by the MCI two times alone this year, the medical college has finally got the approval for 150 MBBS admissions.
According to a recent report by The New Indian Express, the apex Medical Council accorded recognition to the medical college on August 31, which was the last day of the counselling. Information to this effect is not available on the council official website.
With the last date of admissions for this year being over, the counselling for the convenor seats for MBBS at the Malla Reddy Institute of Medical Sciences has been currently put on hold.
Read Also: MCI disapproves MBBS admissions at Malla Reddy Institute of Medical Sciences
However, the aspirants and the activist association, Healthcare Reforms Doctors Association (HRDA), have alleged irregularities in the admission process.
"While the fee for seats under B category is Rs 11 lakh per annum, and that of C category is Rs 22 lakh yearly, activists claim that the college management was selling all the seats, without counselling, for Rs 22 lakh. Some seats are even being sold for Rs 1.2 crore," the activist association alleged.
TNIE reports that the alleged scam worth Rs 200 crore is swirling around the college's admission process. "The University has not uploaded the MCI letter granting recognition to MRIMS. There is no clarity if permission has been given only to fill seats under management quota, but one thing is for sure that the college is taking advantage of the situation and selling the convenor quota seats without conducting any counselling and that too at the price of management quota seats," Dr Mahesh Kumar, President of HRDA alleged while having a conversation with the daily.
The same issue of no clarity over the counselling sessions has made the MBBS aspirants anxious too as it has been over two weeks since the recognition but there is still is no information on when, and if, the counselling will be conducted.
When contacted, Dr K Karunakar Reddy, Vice-Chancellor, Kaloji Narayana Rao University of Health Sciences (KNRUHS) has refuted such claims and informed, "The University has already approached the Supreme Court to get an extension on the counselling."
Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd